Heterogeneity of circulating tumor cells in neoadjuvant chemotherapy of breast cancer

Heterogeneity of circulating tumor cells in neoadjuvant chemotherapy of breast cancer

The biological properties of circulating tumor cells (CTCs), and their dynamics during neoadjuvant chemotherapy are important, both for disease progression prediction and therapeutic target determination, with the aim of preventing disease progression. The aim of our study was to estimate of differe...

Full description

Bibliographic Details
Published in:	Molecules Vol. 23, № 4. P. 727 (1-10)
Other Authors:	Savelieva, Olga E., Tashireva, Liubov A., Tarabanovskaya, Natalia A., Simolina, Elena I., Denisov, Evgeny V., Slonimskaya, Elena M., Choynzonov, Evgeny L. 1952-, Perelmuter, Vladimir M., Kaigorodova, Evgeniya V.
Format:	Article
Language:	English
Subjects:	рак молочной железы циркулирующие опухолевые клетки неоадъювантная химиотерапия гетерогенность статьи в журналах
Online Access:	http://vital.lib.tsu.ru/vital/access/manager/Repository/vtls:000787797 Перейти в каталог НБ ТГУ

Similar Items

Circulating tumor cells and bone marrow progenitor cells in the blood of breast cancer patients in the dynamics of neoadjuvant chemotherapy

Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects

CNA landscape of breast tumor, connection with the efficiency of neoadjuvant chemotherapy

Клональная эволюция опухоли молочной железы в процессе неоадъювантной химиотерапии и гематогенное метастазирование = Clonal evolution of breast cancer during neoadjuvant chemotherapy and hematogenous metastasis
by: Ибрагимова, Марина Константиновна

Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples

Copy number aberrations landscape of a breast tumor, connection with the efficiency of neoadjuvant chemotherapy

Intratumoral morphological heterogeneity of breast cancer: Neoadjuvant chemotherapy efficiency and multidrug resistance gene expression

Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy

Microarray research of allelic imbalance in breast cancers during neoadjuvant chemotherapy

Effect of small and radical surgical injury on the level of different populations of circulating tumor cells in the blood of breast cancer patients

Tumor properties mediate the relationship between peripheral blood monocytes and tumor-associated macrophages in breast cancer

Effect of neoadjuvant chemotherapy on correlation of tumor-associated macrophages with angiogenesis and lymphangiogenesis in human breast cancer

Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy

Intratumoral morphological heterogeneity of breast cancer and its implication in chemotherapy resistance

Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy

Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy

Whole transcriptome analysis of breast cancer tumors during neoadjuvant chemotherapy: association with hematogenous metastasis
by: Ibragimova, Marina K.

Clonal evolution of a breast tumor during neoadjuvant chemotherapy and metastasis

Microarray analysis of DNA copy number aberration of the BRCA1 gene in breast tumor: correlation with the efficacy of neoadjuvant chemotherapy

The effect of neoadjuvant chemotherapy on the correlation of tumor-associated macrophages with CD31 and LYVE-1

Circulating tumor cells
by: Romanov, R. V.

Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis

Predictive value of vascular endothelial growth factor receptor type 2 in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

Характеристика транскриптома циркулирующих моноцитов при раке молочной железы
by: Простакишина, Елизавета Андреевна

The study of CNA-status (copy number aberration) of tumor cells in patients with breast cancer

Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44+CD24- stemness

DNA copy number aberrations and expression of ABC transporter genes in breast tumour: Correlation with the effect of neoadjuvant chemotherapy and prognosis of the disease

Heterogeneity of premetastatic niche gene expression in breast cancer cells

Клонально-инвазивные и опухоле-стволовые основы формирования внутриопухолевой морфологической гетерогенности рака молочной железы
by: Денисов, Евгений Владимирович

Determination of BRCAness phenotype in breast tumors for the appointment of neoadjuvant chemotherapy based on platinum and taxanes

Heterogeneity in breast tumor microenvironment: A report from one case

Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles

Spatial transcriptomic analysis of tumor tissue in ovarian cancer patients treated with neoadjuvant chemotherapy

Predictive and prognostic significance of mRNA expression and DNA copies aberrations of ERCC1, RRM1, TOP1, TOP2A, TUBB3, TYMS, and GSTP1 genes in patients with breast cancer

Mutations of BRCA1, BRCA2, and PALB2 genes in breast tumor tissue: Relationship with the effectiveness of neoadjuvant chemotherapy and disease prognosis

Клональная эволюция опухоли молочной железы и гематогенное метастазирование в процессе неоадъювантной химиотерапии

Несбалансированные хромосомные аномалии в опухоли молочной железы и эффективность неоадъювантной химиотерапии

Аллельный имбаланс в опухоли молочной железы при проведении неоадъювантной химиотерапии

Персонализированный подход к назначению неоадъювантной химиотерапии больным с люминальным В раком молочной железы на основании молекулярно-генетических характеристик опухоли

Почему неоадъювантная химиотерапия, за исключением случаев полной регрессии, не улучшает выживаемость больных раком молочной железы